Zenner J. Patrick's most recent trade in Cartesian Therapeutics Inc was a trade of 7,800 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on Jan. 2, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Cartesian Therapeutics Inc | Patrick J. Zenner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 7,800 | 7,800 | - | - | Stock Option (Right to Buy) | |
| Cartesian Therapeutics Inc | Patrick J. Zenner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2026 | 2,600 | 12,974 (0%) | 0% | 0 | Common Stock | |
| Cartesian Therapeutics Inc | Patrick J. Zenner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 7,800 | 7,800 | - | - | Stock Option (Right to Buy) | |
| Cartesian Therapeutics Inc | Patrick J. Zenner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2025 | 2,600 | 10,374 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Zenner J. Patrick | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 228,000 | 228,000 | - | - | Stock Option (Right to Buy) | |
| Selecta Biosciences Inc | Zenner Patrick J. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2024 | 178,000 | 233,248 (0%) | 0% | 0 | Common Stock | |
| Selecta Biosciences Inc | Patrick J. Zenner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 02 Jan 2023 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) | |
| West Pharma Services | Patrick J. Zenner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Mar 2022 | 49 | 10,928 | - | - | Phantom Stock Unit | |
| Selecta Biosciences Inc | Patrick J. Zenner | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jan 2022 | 40,000 | 40,000 | - | - | Stock Option (Right to Buy) |